• Thumbnail for Dopamine releasing agent
    norepinephrine–dopamine releasing agents (NDRAs) like amphetamine and methamphetamine, serotonin–norepinephrine–dopamine releasing agents (SNDRAs) like...
    29 KB (3,168 words) - 20:38, 29 May 2025
  • serotonin–norepinephrine–dopamine releasing agent (SNDRA), also known as a triple releasing agent (TRA), is a type of drug which induces the release of...
    4 KB (378 words) - 15:13, 13 February 2025
  • Thumbnail for Serotonin–dopamine releasing agent
    A serotonindopamine releasing agent (SDRA) is a type of drug which induces the release of serotonin and dopamine in the body and/or brain. SDRAs are...
    20 KB (1,675 words) - 17:13, 9 April 2025
  • Thumbnail for Serotonin releasing agent
    A serotonin releasing agent (SRA) is a type of drug that induces the release of serotonin into the neuronal synaptic cleft. A selective serotonin releasing...
    72 KB (8,007 words) - 14:03, 26 May 2025
  • Thumbnail for Serotonin–norepinephrine releasing agent
    releasing agent Serotonin releasing agent Norepinephrine releasing agent Serotonin–dopamine releasing agent Serotonin–norepinephrine–dopamine releasing agent...
    1 KB (108 words) - 15:12, 13 February 2025
  • Thumbnail for Norepinephrine–dopamine releasing agent
    agent Dopamine releasing agent Norepinephrine releasing agent Serotonin–norepinephrine–dopamine releasing agent Rothman RB, Baumann MH (October 2003). "Monoamine...
    7 KB (556 words) - 21:37, 14 January 2025
  • Thumbnail for Serotonin–dopamine reuptake inhibitor
    related type of drug is a serotonin–dopamine releasing agent (SDRA). Relative to serotonin–norepinephrine–dopamine reuptake inhibitors (SNDRIs), which...
    16 KB (1,791 words) - 22:09, 29 May 2025
  • Thumbnail for Norepinephrine–dopamine reuptake inhibitor
    monoamine releasing agents. Norepinephrine–dopamine releasing agents (NDRAs) like amphetamine and methamphetamine not only induce monoamine release but also...
    5 KB (463 words) - 05:51, 28 January 2025
  • Thumbnail for Norepinephrine releasing agent
    releasing agent Serotonin releasing agent Dopamine releasing agent Serotonin–norepinephrine releasing agent Norepinephrine–dopamine releasing agent...
    18 KB (1,747 words) - 15:13, 13 February 2025
  • Thumbnail for Monoamine releasing agent
    ephedrine, levomethamphetamine) Dopamine releasing agent (DRA) (no robustly selective agents known) Serotonin releasing agent (SRA) (e.g., chlorphentermine...
    263 KB (22,099 words) - 23:59, 9 May 2025
  • Thumbnail for 3-Methoxymethcathinone
    3-Methoxymethcathinone (category Serotonin-dopamine releasing agents)
    Similarly to other cathinones, it acts as a monoamine releasing agent, including of serotonin, dopamine, and norepinephrine. However, in contrast to cathinones...
    6 KB (415 words) - 06:05, 9 April 2025
  • Thumbnail for Monoamine-depleting agent
    Monoamine-depleting agents are a group of drugs which reversibly deplete one or more of the monoamine neurotransmitters – serotonin, dopamine, and norepinephrine...
    4 KB (341 words) - 13:12, 22 May 2025
  • Thumbnail for BK-NM-AMT
    BK-NM-AMT (category Serotonin-dopamine releasing agents)
    N-dimethyl-β-ketotryptamine, as well as 3-indoylmethcathinone, is a serotonindopamine releasing agent (SDRA) and putative entactogen of the tryptamine, α-alkyltryptamine...
    11 KB (698 words) - 06:49, 8 May 2025
  • Thumbnail for 3,4-Ethylenedioxymethcathinone
    3,4-Ethylenedioxymethcathinone (category Serotonin-norepinephrine-dopamine releasing agents)
    4-ethylenedioxymethamphetamine (EDMA). EDMC acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA). Its EC50Tooltip half-maximal effective concentration...
    5 KB (369 words) - 13:36, 11 April 2025
  • Thumbnail for Serotonin reuptake inhibitor
    of MRIs include dopamine reuptake inhibitors and norepinephrine reuptake inhibitors. SRIs are not synonymous with selective serotonin reuptake inhibitors...
    11 KB (843 words) - 10:04, 13 March 2024
  • Thumbnail for Propylone
    Propylone (category Serotonin-dopamine releasing agents)
    specifically as a weak partial serotonin–dopamine releasing agent (SDRA) and serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI), with EC50Tooltip...
    5 KB (337 words) - 09:18, 18 March 2025
  • α-Methyltryptamine [αMT] (Indopan) – non-selective serotonin receptor agonist, serotonin–norepinephrine–dopamine releasing agent (SNDRA), and weak RIMA Etryptamine [α-Ethyltryptamine...
    18 KB (1,537 words) - 20:49, 7 May 2025
  • Thumbnail for 3-Chlorophenmetrazine
    3-Chlorophenmetrazine (category Serotonin-norepinephrine-dopamine releasing agents)
    has been shown to act as a norepinephrine–dopamine releasing agent (NDRA) with additional weak serotonin release. Its EC50Tooltip half-maximal effective...
    3 KB (237 words) - 04:26, 17 January 2025
  • Thumbnail for Phentermine
    Phentermine (category Norepinephrine-dopamine releasing agents)
    combination of phentermine with a serotonin releasing agent (SRA) like fenfluramine results in suppression of brain dopamine release by phentermine and marked...
    44 KB (4,028 words) - 15:33, 30 May 2025
  • Thumbnail for Monoamine neurotoxin
    research suggests that simultaneous induction of serotonin and dopamine release, serotonin depletion, dopamine uptake and metabolism, hyperthermia, oxidative...
    47 KB (4,303 words) - 07:33, 20 February 2025
  • Thumbnail for Reuptake enhancer
    at the dopamine transporter, extracts of Caulis Sinomenii activate DA/NE transporters. Reuptake inhibitor (RI) Releasing agent (RA) Serotonin modulator...
    4 KB (403 words) - 22:10, 12 January 2024
  • Thumbnail for Tryptamine
    Tryptamine (category Serotonin-norepinephrine-dopamine releasing agents)
    Tryptamine has been found to act as a monoamine releasing agent (MRA). It is a releaser of serotonin, dopamine, and norepinephrine, in that order of potency...
    55 KB (4,245 words) - 23:15, 23 May 2025
  • Thumbnail for EDMA
    EDMA (category Serotonin-norepinephrine-dopamine releasing agents)
    non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release. However, subsequent...
    5 KB (332 words) - 08:09, 16 May 2025
  • Thumbnail for 5-Fluorotryptamine
    5-Fluorotryptamine (category Serotonin-dopamine releasing agents)
    addition to its serotonin receptor agonism, 5-FT is a serotonindopamine releasing agent (SDRA), with EC50 values for induction of monoamine release of 10.1 nM...
    12 KB (1,122 words) - 06:48, 27 March 2025
  • Thumbnail for Motivation-enhancing drug
    generally dopaminergic agents, for instance dopamine reuptake inhibitors (DRIs) like methylphenidate and modafinil, dopamine releasing agents (DRAs) like amphetamine...
    111 KB (12,229 words) - 21:34, 29 May 2025
  • Thumbnail for 5-Fluoro-AET
    5-Fluoro-AET (category Serotonin-dopamine releasing agents)
    tryptamine derivative which acts as a serotonindopamine releasing agent (SDRA) and as an agonist of the serotonin 5-HT2A receptor. Its EC50Tooltip half-maximal...
    5 KB (406 words) - 06:48, 8 May 2025
  • Thumbnail for Locomotor activity
    and cocaine-like effects of dopamine releasing agents (DRAs) with varying capacities to release norepinephrine and serotonin in rodents and monkeys have...
    114 KB (12,382 words) - 04:41, 2 June 2025
  • Thumbnail for Serotonin
    rather than serotonin. The entactogen MDMA is a serotonin releasing agent and, while it also possesses other actions such as concomitant release of norepinephrine...
    173 KB (18,295 words) - 19:45, 2 June 2025
  • Thumbnail for 4-Hydroxy-3-methoxymethamphetamine
    4-Hydroxy-3-methoxymethamphetamine (category Serotonin-norepinephrine-dopamine releasing agents)
    a monoamine releasing agent in vitro. Nonetheless, HMMA has been found to induce the release of serotonin, norepinephrine, and dopamine with EC50Tooltip...
    6 KB (409 words) - 11:54, 14 March 2025
  • Thumbnail for Etilamfetamine
    Etilamfetamine (category Norepinephrine-dopamine releasing agents)
    norepinephrine, dopamine, and serotonin, respectively. Hence, dextroethylamphetamine acts as a norepinephrine–dopamine releasing agent (NDRA) with weak...
    19 KB (1,367 words) - 00:00, 10 May 2025